carnosine has been researched along with Diabetic Glomerulosclerosis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 9 (47.37) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, L; Li, YY; Liu, XQ; Sun, YT; Wu, YG; Xia, LL; Zeng, HX; Zhu, W | 1 |
| Albrecht, T; Bakker, SJL; Gretz, N; Hettler, SA; Krämer, BK; Pastene, DO; Perciaccante, R; Qiu, J; Rodriguez-Niño, A; Vajpayee, S; van den Born, J; Yard, BA | 1 |
| Chang, YP; Cheng, HW; Kuo, CW; Lin, CC; Liu, WS; Lu, SH; Tong, ZJ; Tsai, MT; Tsou, HH; Wang, HT; Yen, PC | 1 |
| Jiang, L; Lei, L; Liu, XQ; Nie, ZY; Wang, S; Wu, YG; Yard, B; Zeng, HX; Zhang, Q; Zhang, SQ; Zhu, W | 1 |
| Cao, Y; Cui, D; Liu, L; Shen, B; Wu, Y; Xu, J; Zhang, Q; Zhang, S | 1 |
| Satirapoj, B; Siriwattanasit, N; Supasyndh, O | 1 |
| Baelde, H; Derave, W; Everaert, I; Hanssens, M; Stautemas, J; van Aanhold, C; Van der Stede, T; Vanhaecke, L | 1 |
| El-Hamamsy, M; El-Naggar, AR; Elbarbary, NS; Hamouda, MH; Ismail, EAR | 1 |
| Aldini, G; Blasetti Fantauzzi, C; Giaccari, A; Iacobini, C; Lapolla, A; Menini, S; Orioli, M; Pesce, CM; Pugliese, G; Salomone, E | 1 |
| Peters, V; Schmitt, CP; Yard, B | 1 |
| Kilis-Pstrusinska, K | 2 |
| Blasetti Fantauzzi, C; Iacobini, C; Menini, S; Pugliese, G; Ricci, C | 1 |
| Albrecht, T; Aldini, G; Anna Altomare, A; Baelde, H; Braun, JD; de Heer, E; Denisi, A; Hauske, SJ; Köppel, H; Krämer, BK; Pastene, DO; Qiu, J; Regazzoni, L; Rodriguez, A; Schilperoort, M; van den Born, J; Yard, BA; Zhang, S | 1 |
| Brismar, K; Forsberg, E; Gross, ML; Peters, V; Schmitt, CP; Zschocke, J | 1 |
| Aldini, G; Baelde, H; De Heer, E; Delanghe, J; Derave, W; Everaert, I; Sauerhöfer, S; Taes, Y; Vanhee, L; Yard, B; Zutinic, A | 1 |
| Baelde, H; Bakker, SJ; Bartram, CR; Brinkkoetter, P; Cerna, M; de Heer, E; Fischer, C; Hammes, HP; Hohenadel, D; Janssen, B; Köppel, H; Mathieson, P; Meyer, J; Nawroth, P; Peters, V; Rind, N; Romzova, M; Rondeau, E; Rychlik, I; Saleem, MA; Sauerhoefer, S; van der Woude, FJ; Yard, BA; Zirie, M; Zschocke, J | 1 |
| Bowden, DW; Freedman, BI; Hicks, PJ; Janssen, B; Langefeld, CD; McDonough, C; Pierson, ED; Rich, SS; Sale, MM; van der Woude, FJ; Xu, J; Yard, BA | 1 |
| Braun, GS; Deinzer, M; Floege, J; Gretz, N; Kriz, W; Moeller, MJ; Neumaier, M; Sauerhöfer, S; van der Woude, F; Yuan, G | 1 |
3 review(s) available for carnosine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Carnosine and Diabetic Nephropathy.
Topics: Carnosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidases; Humans; Kidney | 2020 |
Carnosine and Kidney Diseases: What We Currently Know?
Topics: Acute Kidney Injury; Carnosine; Diabetic Nephropathies; Dipeptidases; Humans; Kidney | 2020 |
[Carnosine, carnosinase and kidney diseases].
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Carnosine; Diabetic Nephropathies; Dipeptidases; Free Radical Scavengers; Gentamicins; Humans; Kidney; Kidney Diseases; Polymorphism, Genetic; Reactive Oxygen Species; Reperfusion Injury | 2012 |
3 trial(s) available for carnosine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial.
Topics: Albuminuria; Biomarkers; Blood Urea Nitrogen; Carnosine; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Supplements; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Transforming Growth Factor beta | 2021 |
The effect of 12 weeks carnosine supplementation on renal functional integrity and oxidative stress in pediatric patients with diabetic nephropathy: a randomized placebo-controlled trial.
Topics: Adolescent; Albuminuria; Alpha-Globulins; Biomarkers; Carnosine; Child; Diabetic Nephropathies; Dietary Supplements; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Kidney; Lipids; Male; Oxidative Stress; Prospective Studies | 2018 |
A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.
Topics: Adult; Aged; Alleles; Carnosine; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidases; Europe; Female; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Humans; Kidney Failure, Chronic; Leucine; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Trinucleotide Repeats; United States; White People | 2007 |
13 other study(ies) available for carnosine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis.
Topics: Animals; Carnosine; Caspase 1; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation, Enzymologic; Male; Mice; Mice, Inbred C57BL; Pyroptosis; Random Allocation | 2021 |
Influence of carnosine and carnosinase-1 on diabetes-induced afferent arteriole vasodilation: implications for glomerular hemodynamics.
Topics: Animals; Arterioles; Carnosine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dipeptidases; Humans; Hypertrophy; Mice; Mice, Inbred Strains; Mice, Transgenic; Vasodilation | 2022 |
Acrolein plays a culprit role in the pathogenesis of diabetic nephropathy in vitro and in vivo.
Topics: Acetylcysteine; Acrolein; Animals; Carnosine; Cytokines; Diabetes Mellitus; Diabetic Nephropathies; Environmental Pollutants; HEK293 Cells; Humans; Hydralazine; Kidney; Mice; Streptozocin | 2022 |
Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.
Topics: Adult; Animals; Apoptosis; Biomarkers; Carnosine; Cell Survival; Cytoprotection; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Models, Animal; Down-Regulation; Epithelial Cells; Extracellular Matrix; Female; Fibrosis; Glucose; Glycine N-Methyltransferase; Humans; Inflammation; Kidney; Male; Mice, Inbred C57BL; Middle Aged; Molecular Targeted Therapy; Streptozocin | 2020 |
Protective effect of carnosine on hydrogen peroxide-induced oxidative stress in human kidney tubular epithelial cells.
Topics: Apoptosis; Carnosine; Cell Line; Cell Survival; Diabetic Nephropathies; Epithelial Cells; Humans; Hydrogen Peroxide; Kidney Tubules, Proximal; Membrane Potential, Mitochondrial; NADPH Oxidase 4; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase | 2021 |
Oral anserine supplementation does not attenuate type-2 diabetes or diabetic nephropathy in BTBR ob/ob mice.
Topics: Administration, Oral; Animals; Anserine; Blood Glucose; Carnosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Limit of Detection; Mice; Obesity | 2021 |
FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice.
Topics: Animals; Biological Availability; Carnosine; Cells, Cultured; Diabetic Nephropathies; Dipeptidases; Disease Progression; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Random Allocation | 2018 |
Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice.
Topics: Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Carnosine; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Disease Progression; Female; Glycation End Products, Advanced; Kidney; Mice; Mice, Knockout; Plaque, Atherosclerotic; Signal Transduction; Time Factors | 2015 |
Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice.
Topics: Administration, Oral; Albuminuria; Animals; Blood Glucose; C-Peptide; Carnosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidases; Disease Models, Animal; Gene Expression; Glomerular Mesangium; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Kidney Glomerulus; Male; Mice; Mice, Obese; Organ Size | 2017 |
Carnosine treatment largely prevents alterations of renal carnosine metabolism in diabetic mice.
Topics: Age Factors; Animals; Animals, Genetically Modified; Anserine; Capillary Permeability; Carnosine; Diabetes Mellitus; Diabetic Nephropathies; Dipeptidases; Disease Models, Animal; Humans; Kidney; Mice; Proteinuria | 2012 |
Low plasma carnosinase activity promotes carnosinemia after carnosine ingestion in humans.
Topics: Administration, Oral; Adult; beta-Alanine; Carnosine; Chromatography, High Pressure Liquid; Diabetic Nephropathies; Dipeptidases; Female; Humans; Male | 2012 |
Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.
Topics: Aged; Carnosine; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidases; Female; Gene Expression; Genetic Predisposition to Disease; Glucose; Humans; Kidney; Leucine; Male; Middle Aged; Repetitive Sequences, Amino Acid; RNA, Messenger; Sequence Alignment | 2005 |
L-carnosine, a substrate of carnosinase-1, influences glucose metabolism.
Topics: Animals; Blood Glucose; Carnosine; Cloning, Molecular; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidases; Disease Models, Animal; Genetic Predisposition to Disease; Genetic Variation; Glycated Hemoglobin; Humans; Mice; Mice, Inbred Strains; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity; Transfection | 2007 |